These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 9495018)
41. 4 (or 5)-diazoimidazole-5 (or 4)-carboxamide and related triazenoimidazoles as antibacterial agents: their effects on nucleic acid metabolism of Escherichia coli B. Yamamoto I Biochem Pharmacol; 1969 Jun; 18(6):1463-72. PubMed ID: 4895017 [No Abstract] [Full Text] [Related]
42. Investigations on the mode of action of Triclosan, a broad spectrum antimicrobial agent. Regös J; Hitz HR Zentralbl Bakteriol Orig A; 1974 Mar; 226(3):390-401. PubMed ID: 4151803 [No Abstract] [Full Text] [Related]
43. Structure-based design of an indolicidin peptide analogue with increased protease stability. Rozek A; Powers JP; Friedrich CL; Hancock RE Biochemistry; 2003 Dec; 42(48):14130-8. PubMed ID: 14640680 [TBL] [Abstract][Full Text] [Related]
44. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Park CB; Kim HS; Kim SC Biochem Biophys Res Commun; 1998 Mar; 244(1):253-7. PubMed ID: 9514864 [TBL] [Abstract][Full Text] [Related]
45. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis. Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054 [TBL] [Abstract][Full Text] [Related]
46. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Wu M; Maier E; Benz R; Hancock RE Biochemistry; 1999 Jun; 38(22):7235-42. PubMed ID: 10353835 [TBL] [Abstract][Full Text] [Related]
47. Nature of trimethoprim-induced death in Escherichia coli. Angehrn P; Then R Arzneimittelforschung; 1973 Mar; 23(3):447-51. PubMed ID: 4575177 [No Abstract] [Full Text] [Related]
48. Genome-wide transcriptional profiling of the Escherichia coli response to a proline-rich antimicrobial peptide. Tomasinsig L; Scocchi M; Mettulio R; Zanetti M Antimicrob Agents Chemother; 2004 Sep; 48(9):3260-7. PubMed ID: 15328082 [TBL] [Abstract][Full Text] [Related]
49. Differential antibacterial activity of genistein arising from global inhibition of DNA, RNA and protein synthesis in some bacterial strains. Ulanowska K; Tkaczyk A; Konopa G; Wegrzyn G Arch Microbiol; 2006 Jan; 184(5):271-8. PubMed ID: 16328542 [TBL] [Abstract][Full Text] [Related]
50. Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coli. Lee JK; Seo CH; Luchian T; Park Y Antimicrob Agents Chemother; 2016 Jan; 60(1):495-506. PubMed ID: 26552969 [TBL] [Abstract][Full Text] [Related]
51. Fungicidal effect of indolicidin and its interaction with phospholipid membranes. Lee DG; Kim HK; Kim SA; Park Y; Park SC; Jang SH; Hahm KS Biochem Biophys Res Commun; 2003 May; 305(2):305-10. PubMed ID: 12745074 [TBL] [Abstract][Full Text] [Related]
52. Ficellomycin and feldamycin; inhibitors of bacterial semiconservative DNA replication. Reusser F Biochemistry; 1977 Jul; 16(15):3406-12. PubMed ID: 329871 [TBL] [Abstract][Full Text] [Related]
53. Plasticity in structure and interactions is critical for the action of indolicidin, an antibacterial peptide of innate immune origin. Nagpal S; Kaur KJ; Jain D; Salunke DM Protein Sci; 2002 Sep; 11(9):2158-67. PubMed ID: 12192071 [TBL] [Abstract][Full Text] [Related]
54. Mechanism of action of negamycin in Escherichia coli K12. I. Inhibition of initiation of protein synthesis. Mizuno S; Nitta K; Umezawa H Jpn J Antibiot; 1970 Dec; 23(6):581-8. PubMed ID: 4923582 [No Abstract] [Full Text] [Related]
55. The concentration-dependent membrane activity of cecropin A. Silvestro L; Gupta K; Weiser JN; Axelsen PH Biochemistry; 1997 Sep; 36(38):11452-60. PubMed ID: 9298965 [TBL] [Abstract][Full Text] [Related]
56. Recombinant expression, antimicrobial activity and mechanism of action of tritrpticin analogs containing fluoro-tryptophan residues. Arias M; Hoffarth ER; Ishida H; Aramini JM; Vogel HJ Biochim Biophys Acta; 2016 May; 1858(5):1012-23. PubMed ID: 26724205 [TBL] [Abstract][Full Text] [Related]
57. Interaction studies of novel cell selective antimicrobial peptides with model membranes and E. coli ATCC 11775. Joshi S; Bisht GS; Rawat DS; Kumar A; Kumar R; Maiti S; Pasha S Biochim Biophys Acta; 2010 Oct; 1798(10):1864-75. PubMed ID: 20599694 [TBL] [Abstract][Full Text] [Related]
58. Effect of compounds with both antitumor and bacteriophage-inducing activities on Escherichia coli nucleic acid synthesis. Heinemann B; Howard AJ Antimicrob Agents Chemother (Bethesda); 1965; 5():488-92. PubMed ID: 5327520 [No Abstract] [Full Text] [Related]
59. Indolicidin-derived antimicrobial peptide analogs with greater bacterial selectivity and requirements for antibacterial and hemolytic activities. Kim SM; Kim JM; Joshi BP; Cho H; Lee KH Biochim Biophys Acta; 2009 Feb; 1794(2):185-92. PubMed ID: 19038369 [TBL] [Abstract][Full Text] [Related]
60. Isolation and characterization of novel antimicrobial peptides, rugosins A, B and C, from the skin of the frog, Rana rugosa. Suzuki S; Ohe Y; Okubo T; Kakegawa T; Tatemoto K Biochem Biophys Res Commun; 1995 Jul; 212(1):249-54. PubMed ID: 7612013 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]